NTV Asset Management LLC Has $1.35 Million Stake in Thermo Fisher Scientific Inc. (TMO)

NTV Asset Management LLC cut its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,125 shares of the medical research company’s stock after selling 775 shares during the period. NTV Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $1,353,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in TMO. Bank of Nova Scotia Trust Co. bought a new position in shares of Thermo Fisher Scientific during the third quarter worth $106,000. Ropes Wealth Advisors LLC boosted its position in shares of Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after acquiring an additional 97 shares during the last quarter. Atlantic Trust LLC bought a new position in shares of Thermo Fisher Scientific during the second quarter worth $138,000. Acrospire Investment Management LLC boosted its position in shares of Thermo Fisher Scientific by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the medical research company’s stock worth $174,000 after acquiring an additional 400 shares during the last quarter. Finally, Glassman Wealth Services boosted its position in shares of Thermo Fisher Scientific by 23.1% during the second quarter. Glassman Wealth Services now owns 1,039 shares of the medical research company’s stock worth $181,000 after acquiring an additional 195 shares during the last quarter. 86.31% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts recently weighed in on TMO shares. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Evercore ISI initiated coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price objective for the company. Finally, BTIG Research initiated coverage on shares of Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price objective for the company. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $220.50.

Thermo Fisher Scientific Inc. (NYSE TMO) opened at $198.73 on Friday. Thermo Fisher Scientific Inc. has a 12-month low of $151.74 and a 12-month high of $226.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35. The company has a market cap of $83,226.59, a price-to-earnings ratio of 35.49, a price-to-earnings-growth ratio of 1.52 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $5.72 billion. During the same quarter last year, the business earned $2.41 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 22.1% compared to the same quarter last year. equities research analysts forecast that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.71%.

In other news, SVP Gregory J. Herrema sold 33,327 shares of the firm’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $219.70, for a total value of $7,321,941.90. Following the completion of the sale, the senior vice president now owns 60,471 shares in the company, valued at approximately $13,285,478.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Stephen Williamson sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total transaction of $1,046,300.00. Following the completion of the sale, the chief financial officer now owns 30,741 shares of the company’s stock, valued at approximately $6,432,861.66. The disclosure for this sale can be found here. Insiders sold a total of 144,327 shares of company stock valued at $28,680,042 in the last 90 days. Company insiders own 0.49% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “NTV Asset Management LLC Has $1.35 Million Stake in Thermo Fisher Scientific Inc. (TMO)” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://sportsperspectives.com/2018/02/09/ntv-asset-management-llc-has-1-35-million-stake-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply